A Decade of Information on the Use of Cardiac Implantable Electronic Devices and Interventional Electrophysiological Procedures in the European Society of Cardiology Countries: 2017 Report from the European Heart Rhythm Association

M. J.Pekka Raatikainen, David O. Arnar, B. Merkely, Jens Cosedis Nielsen, Gerhard Hindricks, Hein Heidbuchel, John Camm

Research output: Contribution to journalArticle

54 Citations (Scopus)

Abstract

Aims: The aim of this analysis was to provide comprehensive information on invasive cardiac arrhythmia therapies in the European Society of Cardiology (ESC) area over the past 10 years.

Methods and results: The European Heart Rhythm Association (EHRA) has collected data on invasive arrhythmia therapies since 2008. This year 53 of the 56 ESC member countries provided data for the EHRA White Book. Here we present updated data on procedure rates together with information on demographics, economy, vital statistics, local healthcare systems and training activities. Considerable heterogeneity in the access to invasive arrhythmia therapies still exists across the five geographical ESC regions. In 2016, the device implantation rates per million population were 3-6 times higher in the Western region than in the non-European and Eastern ESC member countries. Catheter ablation activity was highest in the Western countries followed by the Northern and Southern areas. In the non-European countries, atrial fibrillation ablation rate was more than tenfold lower than in the European countries. On the other hand, the growth rate over the past ten years was highest in the non-European and Eastern countries. In some Eastern European countries with relative low gross domestic product the procedure rates exceeded the average values.

Conclusion: It was encouraging to note that during the past decade the growth in invasive arrhythmia therapies was greatest in the areas historically with relatively low activity. Nevertheless, there is substantial disparity and continued efforts are needed to improve harmonization of cardiac arrhythmia therapies in the ESC area.

Fingerprint

Cardiac Arrhythmias
Cardiology
Equipment and Supplies
Gross Domestic Product
Therapeutics
Vital Statistics
Catheter Ablation
Growth
Atrial Fibrillation
Teaching
Demography
Delivery of Health Care
Population

Keywords

  • Atrial fibrillation ablation
  • Cardiac resynchronisation defibrillator (CRT-D)
  • Cardiac resynchronisation pacemaker (CRT-P)
  • Catheter ablation
  • Implantable cardioverter defibrillator (ICD)
  • Pacemaker

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Physiology (medical)

Cite this

@article{20d102f3fd284d3795a1bc6ced163abe,
title = "A Decade of Information on the Use of Cardiac Implantable Electronic Devices and Interventional Electrophysiological Procedures in the European Society of Cardiology Countries: 2017 Report from the European Heart Rhythm Association",
abstract = "Aims: The aim of this analysis was to provide comprehensive information on invasive cardiac arrhythmia therapies in the European Society of Cardiology (ESC) area over the past 10 years.Methods and results: The European Heart Rhythm Association (EHRA) has collected data on invasive arrhythmia therapies since 2008. This year 53 of the 56 ESC member countries provided data for the EHRA White Book. Here we present updated data on procedure rates together with information on demographics, economy, vital statistics, local healthcare systems and training activities. Considerable heterogeneity in the access to invasive arrhythmia therapies still exists across the five geographical ESC regions. In 2016, the device implantation rates per million population were 3-6 times higher in the Western region than in the non-European and Eastern ESC member countries. Catheter ablation activity was highest in the Western countries followed by the Northern and Southern areas. In the non-European countries, atrial fibrillation ablation rate was more than tenfold lower than in the European countries. On the other hand, the growth rate over the past ten years was highest in the non-European and Eastern countries. In some Eastern European countries with relative low gross domestic product the procedure rates exceeded the average values.Conclusion: It was encouraging to note that during the past decade the growth in invasive arrhythmia therapies was greatest in the areas historically with relatively low activity. Nevertheless, there is substantial disparity and continued efforts are needed to improve harmonization of cardiac arrhythmia therapies in the ESC area.",
keywords = "Atrial fibrillation ablation, Cardiac resynchronisation defibrillator (CRT-D), Cardiac resynchronisation pacemaker (CRT-P), Catheter ablation, Implantable cardioverter defibrillator (ICD), Pacemaker",
author = "Raatikainen, {M. J.Pekka} and Arnar, {David O.} and B. Merkely and Nielsen, {Jens Cosedis} and Gerhard Hindricks and Hein Heidbuchel and John Camm",
year = "2017",
month = "8",
day = "1",
doi = "10.1093/europace/eux258",
language = "English",
volume = "19",
pages = "ii1--ii90",
journal = "Europace",
issn = "1099-5129",
publisher = "Oxford University Press",
number = "2",

}

TY - JOUR

T1 - A Decade of Information on the Use of Cardiac Implantable Electronic Devices and Interventional Electrophysiological Procedures in the European Society of Cardiology Countries

T2 - 2017 Report from the European Heart Rhythm Association

AU - Raatikainen, M. J.Pekka

AU - Arnar, David O.

AU - Merkely, B.

AU - Nielsen, Jens Cosedis

AU - Hindricks, Gerhard

AU - Heidbuchel, Hein

AU - Camm, John

PY - 2017/8/1

Y1 - 2017/8/1

N2 - Aims: The aim of this analysis was to provide comprehensive information on invasive cardiac arrhythmia therapies in the European Society of Cardiology (ESC) area over the past 10 years.Methods and results: The European Heart Rhythm Association (EHRA) has collected data on invasive arrhythmia therapies since 2008. This year 53 of the 56 ESC member countries provided data for the EHRA White Book. Here we present updated data on procedure rates together with information on demographics, economy, vital statistics, local healthcare systems and training activities. Considerable heterogeneity in the access to invasive arrhythmia therapies still exists across the five geographical ESC regions. In 2016, the device implantation rates per million population were 3-6 times higher in the Western region than in the non-European and Eastern ESC member countries. Catheter ablation activity was highest in the Western countries followed by the Northern and Southern areas. In the non-European countries, atrial fibrillation ablation rate was more than tenfold lower than in the European countries. On the other hand, the growth rate over the past ten years was highest in the non-European and Eastern countries. In some Eastern European countries with relative low gross domestic product the procedure rates exceeded the average values.Conclusion: It was encouraging to note that during the past decade the growth in invasive arrhythmia therapies was greatest in the areas historically with relatively low activity. Nevertheless, there is substantial disparity and continued efforts are needed to improve harmonization of cardiac arrhythmia therapies in the ESC area.

AB - Aims: The aim of this analysis was to provide comprehensive information on invasive cardiac arrhythmia therapies in the European Society of Cardiology (ESC) area over the past 10 years.Methods and results: The European Heart Rhythm Association (EHRA) has collected data on invasive arrhythmia therapies since 2008. This year 53 of the 56 ESC member countries provided data for the EHRA White Book. Here we present updated data on procedure rates together with information on demographics, economy, vital statistics, local healthcare systems and training activities. Considerable heterogeneity in the access to invasive arrhythmia therapies still exists across the five geographical ESC regions. In 2016, the device implantation rates per million population were 3-6 times higher in the Western region than in the non-European and Eastern ESC member countries. Catheter ablation activity was highest in the Western countries followed by the Northern and Southern areas. In the non-European countries, atrial fibrillation ablation rate was more than tenfold lower than in the European countries. On the other hand, the growth rate over the past ten years was highest in the non-European and Eastern countries. In some Eastern European countries with relative low gross domestic product the procedure rates exceeded the average values.Conclusion: It was encouraging to note that during the past decade the growth in invasive arrhythmia therapies was greatest in the areas historically with relatively low activity. Nevertheless, there is substantial disparity and continued efforts are needed to improve harmonization of cardiac arrhythmia therapies in the ESC area.

KW - Atrial fibrillation ablation

KW - Cardiac resynchronisation defibrillator (CRT-D)

KW - Cardiac resynchronisation pacemaker (CRT-P)

KW - Catheter ablation

KW - Implantable cardioverter defibrillator (ICD)

KW - Pacemaker

UR - http://www.scopus.com/inward/record.url?scp=85041677898&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85041677898&partnerID=8YFLogxK

U2 - 10.1093/europace/eux258

DO - 10.1093/europace/eux258

M3 - Article

C2 - 28903470

AN - SCOPUS:85041677898

VL - 19

SP - ii1-ii90

JO - Europace

JF - Europace

SN - 1099-5129

IS - 2

ER -